Skip to main content
Home Beijing 2022 Winter Games
  • News
  • Galleries
  • Medals
  • Schedule
Copy link
Related Topics
United Kingdom General news Health Government and politics Business Disease outbreaks Public health Regulatory agencies Coronavirus Infectious diseases Diseases and conditions Lung disease COVID-19 pandemic Immunizations Vascular disease Cardiovascular disease Healthcare industry regulation Industry regulation Government business and finance Government regulations
More From
Photo Gallery
UK regulator: People should keep getting AstraZeneca shots
Discarded in the safe disposal box are used syringes, that were used to give patient their 1st doses for the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Discarded in the safe disposal box are used syringes, that were used to give patient their 1st doses for the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 08:41 AM EDT
Copy link
Pharmacy Technician Katrina Bonwick draws a does of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Pharmacy Technician Katrina Bonwick draws a does of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:50 AM EDT
Copy link
A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:52 AM EDT
Copy link
FILE - In this  Jan. 11, 2021, file photo, a man receives an injection of the AstraZeneca vaccine at the mass vaccination program in Newcastle Upon Tyne, England. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots.​ Britain and several other countries have stuck with the vaccine. (AP Photo/Scott Heppell, File)

FILE - In this Jan. 11, 2021, file photo, a man receives an injection of the AstraZeneca vaccine at the mass vaccination program in Newcastle Upon Tyne, England. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots.​ Britain and several other countries have stuck with the vaccine. (AP Photo/Scott Heppell, File)

Mar. 15, 2021 08:33 AM EDT
Copy link
A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

Mar. 18, 2021 08:01 AM EDT
Copy link
FILE - In this Feb. 5, 2021, file photo, vials AstraZeneca vaccine ready to be used at the Wellcome Centre in London. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots. Britain and several other countries have stuck with the vaccine. (AP Photo/Frank Augstein, File)

FILE - In this Feb. 5, 2021, file photo, vials AstraZeneca vaccine ready to be used at the Wellcome Centre in London. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots. Britain and several other countries have stuck with the vaccine. (AP Photo/Frank Augstein, File)

Mar. 15, 2021 08:23 AM EDT
Copy link
A woman at the Wheatfield surgery is given a 1st shot of the AstraZeneca COVID-19 vaccine by Dr Christian Owusu-Yianoma in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

A woman at the Wheatfield surgery is given a 1st shot of the AstraZeneca COVID-19 vaccine by Dr Christian Owusu-Yianoma in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:54 AM EDT
Copy link
A vial and syringes ready for use of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

A vial and syringes ready for use of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:50 AM EDT
Copy link
Latest News

Olympic luge champion Johannes Ludwig of Germany retires

2 hrs ago

IOC questions Olympic boxing leadership after IBA election

By Graham Dunbar May. 14, 2022 01:30 PM EDT

China cites pandemic and withdraws as host of 2023 Asian Cup

May. 14, 2022 05:10 AM EDT

Slingsby's Aussies aim for SailGP 3-peat, another $1M check

By Bernie Wilson May. 13, 2022 07:36 PM EDT

Column: US lands 2031 Rugby World Cup, if anyone cares

By Paul Newberry May. 13, 2022 04:14 PM EDT
AP Sports | © 2022 Associated Press
  • Privacy Policy
  • Terms of Use
  • AP News
  • AP Images
  • ap.org